AVGR Quarterly Earnings. Should You Buy?


AVGR Quarterly Earnings. Should You Buy?: Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today reported results for the fourth quarter ended December 31, 2020. Fourth Quarter and Recent Highlights Revenue increased 19% sequentially to $2.7 million, the highest level in […]

Comments

Popular posts from this blog

General Mills Is Raising $1 Billion For Blue Buffalo Purchase - CWEB.com

CWEB - Many household products contain antimicrobial chemicals banned from soaps by the FDA